Assure Tech Hangzhou Co Ltd (688075) - Net Assets
Based on the latest financial reports, Assure Tech Hangzhou Co Ltd (688075) has net assets worth CN¥5.15 Billion CNY (≈ $753.09 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.76 Billion ≈ $842.59 Million USD) and total liabilities (CN¥611.60 Million ≈ $89.50 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Assure Tech Hangzhou Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥5.15 Billion |
| % of Total Assets | 89.38% |
| Annual Growth Rate | 73.26% |
| 5-Year Change | 97.99% |
| 10-Year Change | N/A |
| Growth Volatility | 131.65 |
Assure Tech Hangzhou Co Ltd - Net Assets Trend (2017–2025)
This chart illustrates how Assure Tech Hangzhou Co Ltd's net assets have evolved over time, based on quarterly financial data. See Assure Tech Hangzhou Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Assure Tech Hangzhou Co Ltd (2017–2025)
The table below shows the annual net assets of Assure Tech Hangzhou Co Ltd from 2017 to 2025. For live valuation and market cap data, see 688075 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.16 Billion ≈ $755.16 Million |
-0.75% |
| 2024-12-31 | CN¥5.20 Billion ≈ $760.89 Million |
+1.84% |
| 2023-12-31 | CN¥5.11 Billion ≈ $747.13 Million |
-5.78% |
| 2022-12-31 | CN¥5.42 Billion ≈ $792.94 Million |
+107.89% |
| 2021-12-31 | CN¥2.61 Billion ≈ $381.41 Million |
+221.12% |
| 2020-12-31 | CN¥811.69 Million ≈ $118.78 Million |
+399.92% |
| 2019-12-31 | CN¥162.36 Million ≈ $23.76 Million |
+58.13% |
| 2018-12-31 | CN¥102.68 Million ≈ $15.02 Million |
+61.59% |
| 2017-12-31 | CN¥63.54 Million ≈ $9.30 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Assure Tech Hangzhou Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 28725.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥3.92 Billion | 75.90% |
| Other Components | CN¥1.24 Billion | 24.10% |
| Total Equity | CN¥5.16 Billion | 100.00% |
Assure Tech Hangzhou Co Ltd Competitors by Market Cap
The table below lists competitors of Assure Tech Hangzhou Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SZZT Electronics Co Ltd
SHE:002197
|
$560.98 Million |
|
Happiest Minds Technologies Limited
NSE:HAPPSTMNDS
|
$561.09 Million |
|
Sunny Loan Top Co Ltd
SHG:600830
|
$561.11 Million |
|
Shanghai New World Co Ltd
SHG:600628
|
$561.32 Million |
|
Vamos Locação de Caminhões Máquinas e Equipamentos S.A
SA:VAMO3
|
$560.62 Million |
|
Log-In Logística Intermodal S.A
SA:LOGN3
|
$560.58 Million |
|
Zenitron Corp
TW:3028
|
$560.58 Million |
|
Ceepower Co Ltd
SHE:300062
|
$560.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Assure Tech Hangzhou Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,203,599,188 to 5,164,606,491, a change of -38,992,697 (-0.7%).
- Net income of 73,382,112 contributed positively to equity growth.
- Dividend payments of 101,667,248 reduced retained earnings.
- Other comprehensive income decreased equity by 73,441,233.
- Other factors increased equity by 62,733,672.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥73.38 Million | +1.42% |
| Dividends Paid | CN¥101.67 Million | -1.97% |
| Other Comprehensive Income | CN¥-73.44 Million | -1.42% |
| Other Changes | CN¥62.73 Million | +1.21% |
| Total Change | CN¥- | -0.75% |
Book Value vs Market Value Analysis
This analysis compares Assure Tech Hangzhou Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.74x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 23.13x to 0.74x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥1.30 | CN¥30.16 | x |
| 2018-12-31 | CN¥1.96 | CN¥30.16 | x |
| 2019-12-31 | CN¥1.80 | CN¥30.16 | x |
| 2020-12-31 | CN¥8.52 | CN¥30.16 | x |
| 2021-12-31 | CN¥26.60 | CN¥30.16 | x |
| 2022-12-31 | CN¥42.65 | CN¥30.16 | x |
| 2023-12-31 | CN¥40.07 | CN¥30.16 | x |
| 2024-12-31 | CN¥40.86 | CN¥30.16 | x |
| 2025-12-31 | CN¥40.82 | CN¥30.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Assure Tech Hangzhou Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.42%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.18%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 1.10x
- Recent ROE (1.42%) is below the historical average (25.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -9.26% | -5.28% | 0.70x | 2.52x | CN¥-12.20 Million |
| 2018 | 32.55% | 20.38% | 0.87x | 1.83x | CN¥23.12 Million |
| 2019 | 33.55% | 25.96% | 0.96x | 1.34x | CN¥38.24 Million |
| 2020 | 79.96% | 54.09% | 1.09x | 1.36x | CN¥567.82 Million |
| 2021 | 28.33% | 46.47% | 0.48x | 1.26x | CN¥477.88 Million |
| 2022 | 56.15% | 49.38% | 0.89x | 1.28x | CN¥2.50 Billion |
| 2023 | 2.77% | 28.12% | 0.09x | 1.13x | CN¥-369.39 Million |
| 2024 | 3.70% | 35.56% | 0.09x | 1.11x | CN¥-328.06 Million |
| 2025 | 1.42% | 16.18% | 0.08x | 1.10x | CN¥-443.08 Million |
Industry Comparison
This section compares Assure Tech Hangzhou Co Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $604,930,526
- Average return on equity (ROE) among peers: 13.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Assure Tech Hangzhou Co Ltd (688075) | CN¥5.15 Billion | -9.26% | 0.12x | $560.86 Million |
| Shenzhen CAU Technology Co Ltd (000004) | $85.02 Million | 26.56% | 2.79x | $53.47 Million |
| Pacific Shuanglin Bio pharmacy Co Ltd (000403) | $64.35 Million | 12.98% | 2.10x | $1.50 Billion |
| Nanhua Bio Medicine Co Ltd (000504) | $128.43 Million | -28.90% | 2.15x | $378.62 Million |
| Jiangsu Sihuan Bioengineering Co Ltd (000518) | $730.78 Million | -9.68% | 0.13x | $470.05 Million |
| Chengzhi Shareholding Co Ltd (000990) | $1.65 Billion | 1.65% | 0.84x | $1.54 Billion |
| Hualan Biological EngineeringInc (002007) | $94.10 Million | 30.66% | 1.57x | $3.43 Billion |
| Da An Gene Co Ltd of Sun Yat-Sen University (002030) | $626.21 Million | 14.40% | 0.46x | $1.14 Billion |
| Shanghai RAAS Blood Products Co Ltd Class A (002252) | $170.01 Million | 48.10% | 0.80x | $4.52 Billion |
| Baolingbao Biology Co Ltd (002286) | $238.05 Million | 18.81% | 2.12x | $496.75 Million |
| Tibet Cheezheng Tibetan Medicine Co Ltd (002287) | $2.26 Billion | 16.10% | 0.32x | $1.64 Billion |
About Assure Tech Hangzhou Co Ltd
Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veteri… Read more